NeuroSolv Therapeutics Developing New Therapy to Treat Spinal Cord Injury, Partners With AscellaHealth to Bring Therapy to Market
DUBLIN--(BUSINESS WIRE)--Jul 11, 2023--
Source: joplinglobe.com
Stay updated with breaking news from Solv Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DUBLIN--(BUSINESS WIRE)--Jul 11, 2023--
Initial research indicates that PerinelineTM, which received Orphan Drug Designation in 2022 may improve neuroplasticity and neuroregeneration to enable new synapses to be made. Pre-clinical data indicates that the therapy may improve mobility in both acute and chronic cases.DUBLIN--(BUSINESS WIRE)--In partnership w...